SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 21.25
+1.25 (6.25%)
Apr 17, 2025, 4:12 PM GMT+1
SkinBioTherapeutics Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
| Cash & Equivalents | 1.24 | 0.8 | 1.31 | 1.8 | 4.61 | 2.16 | Upgrade
|
| Cash & Short-Term Investments | 1.24 | 0.8 | 1.31 | 1.8 | 4.61 | 2.16 | Upgrade
|
| Cash Growth | -56.45% | -38.95% | -27.32% | -60.85% | 113.51% | -30.91% | Upgrade
|
| Accounts Receivable | 0.5 | 0.28 | 0 | 0 | - | - | Upgrade
|
| Other Receivables | - | 0.06 | 0.3 | 0.33 | 0.21 | 0.14 | Upgrade
|
| Receivables | 0.5 | 0.34 | 0.3 | 0.33 | 0.21 | 0.14 | Upgrade
|
| Inventory | 0.83 | 0.47 | 0.03 | 0.12 | - | - | Upgrade
|
| Prepaid Expenses | - | 0.06 | 0.07 | 0.08 | 0.24 | 0.05 | Upgrade
|
| Total Current Assets | 2.57 | 1.67 | 1.72 | 2.33 | 5.06 | 2.35 | Upgrade
|
| Property, Plant & Equipment | 0.48 | 0.12 | 0.17 | 0.13 | 0.14 | 0 | Upgrade
|
| Goodwill | 2.32 | 2.04 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 1.93 | 1.39 | 0.7 | 0.63 | 0.53 | 0.42 | Upgrade
|
| Total Assets | 7.3 | 5.22 | 2.59 | 3.08 | 5.73 | 2.77 | Upgrade
|
| Accounts Payable | 0.72 | 0.28 | 0.19 | 0.07 | 0.08 | 0.14 | Upgrade
|
| Accrued Expenses | - | 0.21 | 0.3 | 0.37 | 0.28 | 0.15 | Upgrade
|
| Short-Term Debt | - | 0.74 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | - | Upgrade
|
| Current Income Taxes Payable | 0.16 | 0.03 | - | 0.03 | 0.02 | 0.02 | Upgrade
|
| Other Current Liabilities | 0.5 | 0.5 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Total Current Liabilities | 1.43 | 1.8 | 0.53 | 0.51 | 0.4 | 0.3 | Upgrade
|
| Long-Term Leases | 0.02 | 0.04 | 0.07 | 0.1 | 0.11 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.15 | 0.15 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.25 | 0.25 | - | - | - | - | Upgrade
|
| Total Liabilities | 2.81 | 2.25 | 0.6 | 0.61 | 0.52 | 0.3 | Upgrade
|
| Common Stock | 2.28 | 2.02 | 1.73 | 1.57 | 1.57 | 1.28 | Upgrade
|
| Additional Paid-In Capital | 16.8 | 14.51 | 10.95 | 8.76 | 8.76 | 4.92 | Upgrade
|
| Retained Earnings | -15.03 | -14 | -11.12 | -8.29 | -5.5 | -4.14 | Upgrade
|
| Comprehensive Income & Other | 0.44 | 0.44 | 0.44 | 0.44 | 0.38 | 0.4 | Upgrade
|
| Shareholders' Equity | 4.49 | 2.97 | 1.99 | 2.48 | 5.22 | 2.47 | Upgrade
|
| Total Liabilities & Equity | 7.3 | 5.22 | 2.59 | 3.08 | 5.73 | 2.77 | Upgrade
|
| Total Debt | 1.03 | 0.82 | 0.1 | 0.13 | 0.14 | - | Upgrade
|
| Net Cash (Debt) | 0.21 | -0.02 | 1.21 | 1.68 | 4.47 | 2.16 | Upgrade
|
| Net Cash Growth | -92.33% | - | -27.78% | -62.48% | 107.04% | -30.91% | Upgrade
|
| Net Cash Per Share | 0.00 | -0.00 | 0.01 | 0.01 | 0.03 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 228.44 | 202.26 | 173.14 | 156.78 | 156.78 | 128.08 | Upgrade
|
| Total Common Shares Outstanding | 228.44 | 202.26 | 173.14 | 156.78 | 156.78 | 128.08 | Upgrade
|
| Working Capital | 1.14 | -0.13 | 1.19 | 1.82 | 4.66 | 2.04 | Upgrade
|
| Book Value Per Share | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | Upgrade
|
| Tangible Book Value | 0.24 | -0.46 | 1.29 | 1.85 | 4.69 | 2.05 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | -0.00 | 0.01 | 0.01 | 0.03 | 0.02 | Upgrade
|
| Machinery | - | - | - | - | - | 0.01 | Upgrade
|
Updated Dec 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.